Partner Spotlight | Accel Research Sites

Accel Clinical Services acquires Meridien Research site network, selected as location for Moderna COVID-19 vaccine trial.

 

CHAPEL HILL, NC (July 29, 2020) — Devana Solutions, LLC (Devana) is celebrating their partner-client’s, Accel Clinical Services (parent company to Accel Research Sites), recent acquisition of AMPLIFY’s esteemed Meridien Research site network, NeuroStudies destination research unit, and the InSearch site business development network. Equally celebratory, Accel Research Sites was also chosen as the only Central Florida location to conduct Moderna’s COVE Phase 3 Study in efforts to develop the first COVID-19 vaccine.

Accel, now armed with a team of over 100 researchers, specializing in multi-phase and multi-therapeutic research, is proof that forward-thinking and innovation is the key to success. It was that same forward-thinking that brought them to their decision to partner with Devana, utilizing Devana’s technology’s time-saving automation and powerful data to make their processes more efficient, better therapeutically align them with Sponsors and CROs, and ultimately land more of the right trial opportunities, some being very timely in the COVID-19 era.

“With our recent acquisition, we were able to more than double our size, adding jobs here in Florida and throughout the Southeast and expanding our trial footprint. We are very excited to serve as a site for several COVID-19 trials and have begun enrolling the first of thousands of participants in the Orlando, Florida area. This is a critical time in our industry and our world, and we are proud to be part of developing a vaccine,” said Matt Maxwell, CEO of Accel Research Sites.

Now, more than ever, clinical research organizations need a tool to strengthen their ability to manage the clinical trial process anywhere, anytime and at an efficient pace. Adaptability is what fuels growth in this industry. Devana continues to innovate to meet the needs of this everchanging industry and support research organizations, like Accel, that continue to move the needle and pave the way forward.

“Supporting high growth, tech-enabled research organizations is what Devana Solutions does best,” said Barry Lake, CEO, Devana Solutions, “Accel Research Sites under Matt’s leadership epitomizes high growth and tech-enabled.”

Devana’s support of Accel, especially as they help to develop a potential vaccine against COVID-19, brings their mission to life. The driving force behind this dynamic and disruptive tech company is knowing that their continuous innovations and enduring partnerships will, ultimately, help save lives. That is their motivation.

  

About Accel Clinical Services

Accel Clinical Services is a portfolio of companies dedicated to supporting independent physicians and their patients in the delivery of high-quality medical care. It serves as the parent company to subsidiaries built to align services around the needs of its customers: Accel Research Sites, Accel Trial Connections Network, Accel Patient Communities, Accel Provider Communities, and Accel Research Management.

 

About Accel Research Sites

Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.

 

About Devana Solutions, LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Partner Spotlight | Cedar Health Research

Devana Solutions, LLC (Devana) is pleased to announce their newest client-partnership with Cedar Health Research, a rapidly growing research site network with two Dallas area sites and soon to be expanding throughout Texas and nationally. Cedar Health Research is a strong advocate for technological innovation in the clinical trial space. We are honored that such a proactive and innovative group has chosen Devana to help with their vision to set the gold standard for clinical trial execution.

Cedar’s mission is to “transform the clinical research domain through the effective adoption of innovative technologies in a research site network that produces data with integrity,” so when the initial conversations between Devana and Cedar began, we quickly realized the synergies, after all, data integrity is what Devana Solutions is all about! By partnering with Devana, Cedar will now have real-time transparency into their sites’ performance metrics, helping them to better align with their Sponsor and CRO partners, both therapeutically and operationally.

Aside from leveraging the powerful Devana IGNITE technology for successful trial execution, Cedar is also powered by Aspen Insights, a next-generation technology provider that is changing how researchers find trial patients through the application of artificial intelligence and machine learning. Sites and Sponsors often face several barriers when recruiting for clinical trials, no matter the indication. Slow and inaccurate candidate recruitment, lack of access to a qualified patient population and low physician-engaged recruitment can make finding qualified candidates unfeasible. Cedar Health Research is on a mission to change that by applying Aspen Insights’ artificial intelligence technology that delivers instantaneous, methodical and accurate patient-trial match results.

There is no doubt that Cedar Health Research is well on their way to making quite the impact on the clinical trials industry. The future of research is dependent on the hard work of research organizations like Cedar, as well as the technologies that empower them. Devana Solutions is delighted to stand alongside Cedar as they pave the way with their pioneering mentality.

ABOUT CEDAR HEALTH RESEARCH:

To learn more, visit https://www.cedarhealthresearch.com/. To learn more about Aspen Insights, visit https://aspeninsights.com/.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Partner Spotlight | Circuit Clinical

Devana Solutions is pleased to announce our newest client-partnership with Circuit Clinical, one of the largest Integrated Research Organizations in the United States! Devana Solutions continues to change the game for the industry’s leading research organizations, like Circuit Clinical, with its innovative and disruptive technologies.

Circuit Clinical understands the importance of the physician and patient relationship. Their core belief is that patients prefer to learn about clinical research from the healthcare providers they know and trust, thus the vision for Circuit Clinical emerged in 2015. The Circuit Clinical mission strives to transform the experience of how people find, choose and participate in clinical research. By partnering with physicians, Circuit Clinical gains direct access to interested and qualified patients, opening a door to more than 1-million patients that currently exist within their network. Combining this with their very own technology product, TrialScoutTM, a digital platform that allows patients to find, rate and review their clinical trial experiences, shines a light on a new path forward in clinical research.

Now, with the addition of Devana Solutions, LLC IGNITE cloud software, Circuit Clinical is on an even brighter path with the ability to simplify contact and account management, study start-up and execution, all while seamlessly capturing performance metrics for analytics and reporting for true operational transparency, better-aligning Circuit Clinical with their CRO and Sponsor partners to advance new therapies for the benefit of patients.

“I first met members of the Circuit Clinical team at the SCRS Oncology Summit in Austin, then met Irfan Khan, CEO at the SCOPE Summit a couple weeks later and was incredibly impressed with the people, their passion for research and drive to innovate,” commented Barry Lake, Devana Solutions, CEO “Circuit Clinical’s embrace of Devana IGNITE is a perfect fit with their mission.”

Devana Solutions is honored to have the Circuit Clinical team using their technology to advance medicine!

ABOUT CIRCUIT CLINICAL:

Founded with a vision to transform the participant experience in clinical research, Circuit Clinical, an Integrated Research Organization is comprised of more than 30 multi-specialty groups and 3 ACO’s and an National Cancer Institute with access to more than 1 million lives. Circuit conducts Phase II – Phase IV clinical trials with the top 20 pharmaceutical companies.

Circuit developed the award-winning platform, TrialScout which provides Clinical Research Sites with a powerful patient engagement and retention tool that builds their brand with patients and sponsors. TrialScout supports clinical trials using the first-ever patient experience ratings and reviews, generating unique monthly analytics to optimize Site operations.

In 2019, Circuit Clinical was selected as a winner of the 43North competition – an international event aimed at cultivating high growth and innovative companies. Circuit Clinical (TrialScout) was Runner Up at Disruptive Innovations to Advance Clinical Trials’ innovation competition, DPharm Idol Disrupt (Dpharm 2019). In 2020, Circuit Clinical (TrialScout) is a Participant Engagement Award Finalist at the Society for Clinical Operations Executives annual summit (SCOPE 2020).

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

Partner Spotlight | Segal Trials

 

As we continue to forge through the pandemic, most businesses in this industry have been forced to rethink their current business models. What will clinical trial sites look like now? Perhaps we will see a rise in virtual trials. Maybe we allow some of our employees to work remotely. Possibly a change to our sick policies. Whatever the changes we decide to make, one thing is certain, we must prepare now, since we have been shown that we are not immune to a global health crisis. At Devana Solutions, LLC, we are committed to supporting sites as they make their preparations.

One of our newest client-partners, Segal Trials, a network of six research sites specializing in Phase I-IV trials in Psychiatry and Women’s Health Disorders, has been adjusting their business operations in light of the pandemic. Along with new capabilities, including virtual and in-home visits, they have adopted new technologies to ensure sustainability in our changing industry. They have accomplished these changes without losing site of the community they serve by hosting several mental health and clinical trials awareness events in the month of May, with safety precautions in place, of course.

“Being able to support sites like Segal Trials in their efforts to adapt to this new reality is what Devana Solutions is all about. We hope that through the efficiency that our technology offers, sites are able to focus on what’s most important, the patients,” said Emily Wike, Director of Strategic Partnerships, Devana Solutions, LLC.

Bonnie Segal, President of Segal Trials, commented, “the pandemic made it very clear to us that we need to modify our business model to meet the needs of our evolving industry. Our new partnership with Devana Solutions will be a critical tool for us to make our vision become a reality.”

Although the world has been a bit grim as of late, we are nothing but optimistic for the future of the clinical research industry. Working with sites like Segal Trials, that have remained steadfast in their mission to advance medical research, despite many obstacles, is what gives us hope.

Check out Segal Trials newest capabilities along with their patient and staff centric initiatives here https://www.segaltrials.com/

About Devana Solutions, LLC

Devana Solutions, LLC is developer and provider of cloud-based SaaS technology driven by a core belief that data transparency through technology is critical to aligning the top performing research organizations at the investigative site level with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana offers technology to standardize operational workflows, particularly in study startup, across site functions while allowing for the automated capture, analysis and display of real time performance data across clinical trial industry stakeholders. For more information about Devana Solutions, LLC visit: www.DevanaSolutions.com.

 

Medix and Devana Solutions Offering Suite of Services

 

May 5, 2020 – Medix, a national organization specialized in workforce solutions and recruiting skilled personnel, and Devana Solutions, the leading cloud-based provider of clinical trial automation technology, are offering a suite of services to support clinical site operations through all stages of the pandemic.

The organizations are partnering to offer 90-day subscription and training for Devana’s LITE platform, a remote study startup collaboration tool for small trial sites, along with six hours of Medix Clinical Trial Consulting services on topics such as Budget Review/Amendment, SOP Writing, Emergency Preparedness Plan, Site Culture Assessment and Site Organizational Design.

“The COVID-19 pandemic has been a whirlwind for our industry. Research sites went from being shut down as ‘non-essential’ businesses to being the only path to diagnosis, treatment and prevention of this virus.  The rapid pace of change we are experiencing now is the kick start this industry needed for safer and more efficient scientific innovation,” said Molly Downhour, Medix Clinical Research Strategy Executive. “We’re here to offer short- and long-term measures sites can put in place now in order to maintain the positive changes to clinical research operations that the pandemic has ignited.”

“Our industry has seen a massive expansion of remote work as clinical teams adapt to work in a post-pandemic world,” said Barry Lake, CEO and Co-Founder of Devana Solutions. “Embracing cloud solutions for workflow automation and metrics capture/analysis will be key to site success moving forward.”

Button

About Medix

Medix provides workforce solutions to clients and creates opportunity for talent representing a variety of industries, including Clinical Research, Healthcare and Scientific. Medix has been featured as well as one of Staffing Industry Analysts’ “Largest Staffing Firms in the United States,” as well as one of the “Fastest Growing Staffing Firm in the United States.” Medix has also been ranked as one of the Best & Brightest Places to Work in the Nation for three years and in ClearlyRated’s 2020 “Best of Staffing” Talent Diamond and Client awards for providing constantly excellent service, further earning our reputation as an industry leader. For more information, call (866) 44-MEDIX or visit www.medixteam.com.

About Devana Solutions

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce clinical trial cycle time and costs to deliver new therapies to patients. Devana Solutions offers three platforms, IGNITE, PROPEL and IQ for sponsors and CROs, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. For more information call (877) DEVANA-2 or visit https://devanasolutions.com.

Partner Spotlight | Del Sol Research Management

 

It has been quite an unusual couple of months during the first part of 2020 due to global pandemic, COVID-19, but Devana Solutions, LLC has proven to be more essential than ever, keeping sites and their employees connected throughout the study startup process. We are honored to be such a valuable asset to our client-partners in the clinical research industry, as they continue working hard to bring much needed therapies and vaccines to those who need them most.

One of our outstanding client-partners, working hard to make a difference in the clinical research industry, is Del Sol Research Management in Tucson, Arizona.  Del Sol focuses primarily on Gastrointestinal Disease, Hepatology, Internal Medicine, Women’s Health and Medical Device studies.  With two convenient locations and fifteen full-time employees, including a Recruitment Manager, it is Del Sol’s mission to increase clinical research awareness within their community. In addition to the usual advertising and outreach that most sites do to increase their participant-base, Del Sol takes their efforts a step further by engaging with local advocacy groups and physicians to bring free health screens to impoverished populations, while educating them on clinical research. “All of these collaborations with our medical peers in the community not only increase study awareness, but also allow Del Sol and our employees to give back to our local community, especially in the poorer areas of our metropolitan area. We, as a company, are very passionate about improving the health and providing health care access to the Tucson community,” said Wendy Hotz, President, Del Sol Research Management.

Del Sol’s Senior VP of Clinical Operations was interviewed recently on a local Spanish television station, addressing the growing interest in clinical research within the Tucson Hispanic community and providing answers to questions that research-naïve individuals may have. It is becoming increasingly known that the Hispanic population has a higher rate of Nonalcoholic Fatty Liver Disease than other ethnicities.  Since this disease can be silent for years before symptoms arise, the need for faster diagnosis is more important than ever, so patients can make the necessary lifestyle changes earlier to combat this deadly disease.  Thanks to their in-house Fibroscan®, Del Sol is able to quickly measure liver fibrosis and steatosis of their study participants, making Del Sol an asset to Sponsors and CROs on GI and Hepatic indication-related clinical trials.  In addition to the application of their Fibroscan®, Del Sol has developed expertise in a number of advanced procedures, including serial PK studies, complex infusions, endoscopy, colonoscopy, bile duct stent placement, flexible sigmoidoscopy, biopsy collection from various tissues, sample processing and specimen management,  pulmonary function testing and intrauterine procedures.

With their vast experience and dedication to their patients, staff and CRO/Sponsor relationships, it is no surprise that Del Sol’s excellent reputation precedes them.  We are humbled that they have chosen to partner with Devana Solutions, LLC to continue to revolutionize their clinical trial processes by leveraging our innovative technology platform.  We can’t wait to see what the rest of this year brings for Del Sol!

About Devana Solutions, LLC

Devana Solutions, LLC is developer and provider of cloud-based SaaS technology driven by a core belief that data transparency through technology is critical to aligning the top performing research organizations at the investigative site level with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana offers technology to standardize operational workflows, particularly in study startup, across site functions while allowing for the automated capture, analysis and display of real time performance data across clinical trial industry stakeholders. For more information about Devana Solutions, LLC visit: www.DevanaSolutions.com.

Announcing our Newest Partner-Client – hyperCORE International

Devana Solutions, LLC is one of the clinical research industry’s most innovative technology companies serving and partnering with the industry’s leading research organizations. This week we’re pleased to announce and introduce our latest partner-client: hyperCORE International – the second largest clinical research site organization in the world!

hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. hyperCORE International unifies the clinical research industry’s most respected and advanced research site companies, facilitating a level of unparalleled collaboration. hyperCORE International is an industry leader providing Phase I-IV clinical trial services with more than 81 active research sites across the globe. Its member companies have completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 15,000,000 patients. Each member operates as an independent company but, through the sharing of best practices, hyperCORE International accelerates every aspect of the research site process – from feasibility through study start-up and completion. Its members have won numerous awards for performance, quality and innovation.

hyperCORE International partner members leveraging Devana Solutions, LLC flagship easy-to-use Devana IGNITE cloud software to simplify contact and account management, study start-up and execution, while seamlessly capturing performance metrics for analytics and reporting include: AGA Clinical Trials of Hialeah, Florida; Benchmark Research of Austin, Texas; Clinical Site Partners of Miami, Florida; Clinical Trials of Texas of San Antonio, Texas; DIEX Recherche of Sherbrooke, Canada; IACT Health of Columbus, Georgia; and LMC Manna Research of Toronto, Canada.

In another milestone for Devana Solutions, LLC, these member networks will operate Devana IGNITE in tandem with Devana PROPEL for hyperCORE International providing an operating system to support collaboration across the super network.

The future of clinical research is here. Devana Solutions, LLC, powering better data, better decisions and better outcomes.  #clinicalresearch #clinicaltrials #data #metrics #innovativetechnology

Partner Spotlight | Javara Research

 

2019 was an explosive year of growth for Devana Solutions, LLC, one of the clinical trial industry’s most innovative technology companies, as many of the most recognizable names in the industry launched or expanded their use of the Devana Solutions platform for workflow management, and enhanced data capture and analysis to drive their continued success.

Among Devana’s prominent client-partners is Javara Research, a leading Integrated Research Organization spearheaded by seasoned clinical trials industry leaders including Jennifer Byrne, CEO, Amanda Wright, Vice President of Partnership Development, Susan Donahue, Director of Clinical Trial Operations, Drew Domescik, CFO and Linda McCarty, General Counsel & Privacy Officer. Tegan Mead, Associate Director of Healthcare Engagement – Privia Medical Group (Gulf Coast) rounds out the Javara leadership team who have collectively led over 10,000 trials and engaged more than 200,000 people in clinical trials. The use of advanced technologies like the Devana platform is central to Javara’s mission to make research more efficient and accessible.

In recent months, Javara has announced collaborations to increase patient-access to industry-sponsored, clinical trials with Wake Forest Baptist Medical Center, Tryon Medical Partners and Privia Health’s, Privia Medical Group – Gulf Coast and Georgia.  Javara will lead the effort to deliver clinical research as an innovative care offering to patients engaged with these leading healthcare organizations. Higher rates of clinical trial participation inside of a health system allows for improved access to cutting edge therapies, generating better outcomes and even lower care costs within patient-centered care helping to positively impact the landscape of medicine and healthcare.

Further evidence of Javara’s efforts to innovate and expand patient-access to clinical trials were announced last March when Javara announced the launch of Uber Health rides to lessen the burden for the 3.6 million Americans that miss medical appointments due to a lack of reliable transportation.

“We are truly humbled by the industry leading organizations that have chosen to leverage our Devana technology and Javara definitely epitomizes leadership and innovation in the clinical trials industry,” stated Devana Solutions’ CEO and Co-Founder, Barry Lake.

“Technology is transforming the way in which we conduct clinical research and business. The Devana Ignite for Sites solution allows us to transparently be in tune to our trials, activities and represents a centralized solution that supports the advancement of our business model,” said CEO of Javara, Jennifer Byrne. Javara is proud to lead paths forward that are transforming how clinical research is conducted with exceptional technologies to support.

About Javara, Inc.

Javara, Inc., an Integrated Research Organization (IRO), integrates with complex healthcare systems to ensure clinical research is available throughout the patient care cycle and positions the system to leverage clinical research as a population health strategy, while serving to support drug development needs as a clinical research site provider of high-quality study data. Together, Javara and its healthcare partners offer a more aligned, efficient, and effective solution to the challenges of patient inclusion in clinical trials, by creating an infrastructure where clinical research becomes an integral part of the state-of-the-art healthcare delivery offered by Javara’s healthcare partners. The Javara IRO platform offers better outcomes for patient-centered care, better economic results, easier access to cutting edge therapies for healthcare systems, and a more valuable and reliable research delivery model to the biopharmaceutical sector. For more information about Javara, Inc. visit: JavaraResearch.com.

About Devana Solutions, LLC

Devana Solutions, LLC is developer and provider of cloud-based SaaS technology driven by a core belief that data transparency through technology is critical to aligning the top performing research organizations at the investigative site level with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana offers technology to standardize operational workflows, particularly in study startup, across site functions while allowing for the automated capture, analysis and display of real time performance data across clinical trial industry stakeholders. For more information about Devana Solutions, LLC visit: www.DevanaSolutions.com.

The True Story of the FICO Score – And Why it Matters to Clinical Research Sites

(CHAPEL HILL, NC) – August 15, 2019 (last updated). In recent weeks many of you have heard me making the point that the clinical trial site industry needs more data so that ‘good’ sites can differentiate themselves from ‘bad’ sites.

It would be good for the sites – who will win more business – but more data would also allow CROs a greater ability to select sites that deliver effective clinical trials, ultimately making trials quicker and less costly.

Devana’s IGNITE and PROPEL technology allows important data to be stored and shared by clinical trial sites and site networks as the basis for a scorecard to demonstrate the strength of their performance and case for selection for a clinical trial.

I have often compared the Devana ‘Scorecard’ to the equivalent of a FICO score for the clinical trial site industry. The FICO score is now so commonplace, it struck me that many people do not know the story behind it, the impact it has had on consumer lending and what lessons it holds for the clinical trial site sector.

The FICO score allows banks, credit card companies and other lenders to evaluate the potential risk of lending money to consumers.

Before it existed, lending decisions were based partly on a report prepared on you in utmost secrecy and at the whim of the underwriter at the bank you were applying – apparently the report included such observations as the quality of your furniture and your character!

As ad-hoc and unreliable credit scoring systems were being developed by individual lenders, the FICO Score was developed in 1956 by the engineer William Fair and the mathematician Earl Isaac who had met while working at Stanford. They formed a company Fair, Isaac & Co (the initials of the company spell FICO – which is what the company re-named itself in 2009).

At first, the system was used by individual lenders as private clients of Fair Isaac. The first general purpose FICO score was developed in 1989. Fannie Mae and Freddie Mac began using it in 1995.

To underline how important the FICO score has become in consumer lending, more than 10 BILLION scores are purchased every year by lenders – and more than 100 million Americans have access to their own FICO score.

While the exact formula for calculating a score has never been revealed, we do know it includes weighted consideration of payment history, debt burden, length of credit history, types of credit and recent credit searches.

Just think how much risk has been taken out of lending thanks to the FICO Score.

And consumers, thanks to an amendment to the Fair Credit Reporting Act which passed in 2003, now get free access to their credit reports to gain an understanding of what they need to do to achieve a higher FICO Score to get cheaper loans.

It’s a win-win for both lenders and consumers.

And that’s exactly why we at Devana Solutions believe the clinical trials industry needs that FICO equivalent scorecard for sites and site networks.

The trial sites with good ‘credit’ will use the Devana Scorecard to prove it and win the business they deserve.

Trial sites whose ‘credit’ needs a little mending will know where they need to do to strengthen their game.

And the Sponsors and CROs will have a way of recruiting trial sites that greatly increases site performance predictability and improves clinical trial efficiency and effectiveness.

Another win-win!

About Devana Solutions, LLC

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms to provide historical and real-time data capture, aggregation and display to drug development stakeholders: IGNITE for sites and PROPEL for networks,advanced operations and data analytics technology for sites and site networks and IQ for Sponsors and CROs. www.devanasolutions.com

Contact: Matt Smith, Executive Director, Strategic Partnerships msmith@devanasolutions.com (608) 285-2151

ACRP and Devana Solutions® Announce First Annual Site Metrics Challenge Study Winners

(Chapel Hill, NC) – April 13, 2019. The Association of Clinical Research Professionals (ACRP), a non-profit establishing industry standards for clinical research competence and workforce development, and Devana Solutions, provider of cloud-based metrics capture and data analytics software for clinical trial sites and networks, are excited to announce winners of the 2019 Annual Site Metrics Challenge Study. The study analyzed timing and performance metrics data and the impact of clinical site staff-training by accredited organizations such as ACRP, the leader in clinical trials workforce development and certification.

The study was headlined by three industry-leading Integrated Site Networks: IACT Health, a 17-site network throughout Georgia; LMC Manna Research, at 21 integrated sites across Canada; and PMG Research, Inc., ICON’s integrated site network covering 14 cities in the Mid-Atlantic & Midwest regions. Not surprisingly, each of the headlining site networks won in a category and ranked highly in the other metrics categories. Almost 200 investigative sites participated representing single-location research sites, site networks, highly-specialized sites and academic medical centers.

Participants submitted reports focused on five, specific study start-up and performance metrics which, along with a myriad of other data points, were already being automatically tracked and captured through their usage of Devana Solutions® IGNITE platform by the majority of participants.

Winners of the 2019 ACRP-Devana Solutions Site Metrics Challenge Study are:

Fastest Feasibility Turnaround
1st Place: LMC I Manna Research
2nd Place: MedPharmics

Fastest from Activation to First Screen
ForCare Clinical Research

Fastest Budget & Contract Turnaround Time
Winner in the Site Network Category: PMG Research, Inc.
Winner in the AMC Category: University of Sunshine Coast
Winner in the Specialty Site Category: Raleigh Neurology Associates Clinical Research

Contract Met Percentage
IACT Health

“We conceived of the ACRP-Devana Solutions Site Metrics Challenge Study to try to explore and test a thesis,” according to Jim Kremidas, Executive Director of ACRP, “That thesis being that strong site performance would highly correlate to sites and site networks that had a high commitment to ACRP site staffing, training, and development initiatives. We were pleased – but not surprised – to learn that all of the winning sites and site networks had a strong history and commitment to ACRP training and certification across a very high percentage of their site staff.”

“PMG Research is honored to be recognized for our efforts to decrease start up timelines. Making the clinical trials process more efficient benefits industry partners, sites, and patients by maximizing enrollment opportunity, contributing to faster data analysis, and improving time to market,” said Kathy Cole, Director of Feasibility at PMG Research.

“Devana’s technology facilitates more effective and efficient collaboration through a scalable and centralized platform, providing workflow automation, historical analysis, performance metrics, and custom live reporting from anywhere, any time,” said Simon Corman, Director, Business Development at LMC Manna Research.

“IACT Health has long been a proponent of adopting advanced technologies across our sites and of ACRP’s efforts around staffing, training and development,” stated Jeff Kingsley, CEO of IACT Health, “Clearly, both have contributed in supporting the performance of our dedicated team at IACT.”

ACRP and Devana Solutions believe that this year’s winners and participants will continue to raise the bar for clinical research. By recognizing these outstanding sites and celebrating their achievements, the organizations aim to inspire other high-performing sites to advance their education through ACRP’s training and certification and to improve performance through adopting the Devana IGNITE technology to capture and analyze site metrics toward the overall goal of making the Clinical Research Community stronger.

The ACRP – Devana Solutions First Annual Site Metrics Challenge Study winners will be recognized at the 2019 ACRP Annual Meeting Awards & Recognition Ceremony on April 12, 2019 in Nashville, Tennessee.

Devana Solutions®, LLC is a SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana Solutions® offers three platforms, IGNITE, PROPEL and IQ for sponsors and cros, to provide historical and real-time data capture, aggregation and display to drug development stakeholders.

https://devanasolutions.com/

1 5 6 7 8 9 10